Durvalumab (CD274/B7-H1/PDL1) - Onderzoeksgraad Biosimilar
Gecertificeerd

Durvalumab (CD274/B7-H1/PDL1) - Onderzoeksgraad Biosimilar

Catalog #: 10-680
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

Durvalumab (MEDI 4736) is an humanized anti-PD-L1 monoclonal antibody, it fullyly blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively. ()

Immunogen

Homo sapiens / CD274/B7-H1/PDL1 [Homo sapiens]

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Cancer, Immunology

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

IgG1-kappa

NCBI Organism

Homo sapiens

Other Product Names

MEDI4736

Beschrijving

Durvalumab (CD274/B7-H1/PDL1) - Onderzoeksgraad Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamDurvalumab (CD274/B7-H1/PDL1) - Onderzoeksgraad Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer10-680